National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1265 out of 2,175

Result pages: prev   1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274   next


VAERS ID: 1235030 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-16
Onset:2021-03-17
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6790 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Balance disorder, Dizziness, Dysphagia, Muscular weakness, Nervous system disorder, Pleural effusion, Speech disorder, Visual impairment
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Glaucoma (broad), Optic nerve disorders (broad), Lens disorders (broad), Retinal disorders (broad), Vestibular disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021398779

Write-up: autoimmune neurological syndrome; pulmonary effusions; From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow.; From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow.; From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow/weakness; From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow.; From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow.; From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow.; From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow.; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority. The regulatory authority number is IT-MINISAL02-712445. A 91-year-old female patient received the second dose of BNT162B2 (COMIRNATY, lot number: EJ6790), via an unspecified route of administration, on 16Mar2021, as single dose, for COVID-19 immunisation. Medical history included mild hypertension. The patient''s concomitant medications were not reported. Historical vaccine included the first dose of BNT162B2 (COMIRNATY, lot number: EJ6790), via an unspecified route of administration, on an unspecified date, for COVID-19 immunisation. It was reported that on 17Mar2021 "from the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow". It was also reported that the patient was admitted (unspecified date) where the doctors suspected an autoimmune neurological syndrome (onset date unspecified) and was treated with cortisone and immunosuppressant therapy. On an unspecified date, pulmonary effusions followed and then death. The reporter had no information about the hospitalization and death. The outcome of "from the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow" was fatal; and the outcome of the remaining events was unknown. The patient died on an unspecified date. It was unknown if an autopsy was performed. The health authority assessed the event "from the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow" as serious (fatal). Health authority Comment: On 07Apr2021 additional information is requested from the reporter: Lot number; clinical report on it or other available documentation; concomitant therapies, possibility of contacting a healthcare professional. No follow-up attempts possible. No further information expected.; Reporter''s Comments: mild hypertension; Reported Cause(s) of Death: From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vision problems, dizziness, then inability to hold up, speak, swallow.; From the day after the II dose of covid19 vaccine Pfizer; accused weakness in the legs, vi


VAERS ID: 1235033 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-04-02
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-02
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021408960

Write-up: died from natural causes; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB manufacturer report number IT-MINISAL02-712914. A female patient of an unspecified age received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot Number: ET7205) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient died from natural causes on 02Apr2021. The patient arrived in cardio-respiratory arrest, cardiopulmonary resuscitation maneuvers were performed without success (death) on 02Apr2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: death from natural causes


VAERS ID: 1235034 (history)  
Form: Version 2.0  
Age: 94.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-07
Onset:2021-04-07
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Dyspnoea, Pulmonary embolism
SMQs:, Anaphylactic reaction (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021409121

Write-up: access to the emergency room for dyspnea, died to suspect pulmonary embolism; access to the emergency room for dyspnea, died to suspect pulmonary embolism; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is IT-MINISAL02-713004. A 94-years-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 07Apr2021 14:45 (Lot Number: ET7205; Expiration Date: 31Jul2021) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient experienced dyspnea and pulmonary embolism both on 07Apr2021, with outcome fatal. It is reported vaccination 1st dose with COMIRNATY mRNA vaccine against covid-19 on 07Apr2021 care of the home at 2:45 pm, in the evening, access to the emergency room for dyspnea, died to suspect pulmonary embolism. The patient died on an unspecified date. It was not reported if an autopsy was performed. Sender Comment: On 08Apr2021 request clinical report and if an autopsy examination was performed.; Reported Cause(s) of Death: died to suspect pulmonary embolism; dyspnea


VAERS ID: 1235037 (history)  
Form: Version 2.0  
Age: 88.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-08
Onset:2021-04-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardio-respiratory arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-08
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021409141

Write-up: Patient arrived in the emergency room at 15:55 and died at 16:40 from cardiovascular arrest. Absence of signs and symptoms attributable to anaphylactic shock.; This is a spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is IT-MINISAL02-713425. An 88-years-old male patient received BNT162B2 (COMIRNATY), intramuscular on 08Apr2021 15:36 (Lot Number: ET7205; Expiration Date: 31Jul2021) as 0.5 mL, single for covid-19 immunisation. The patient medical history and patient''s concomitant medications were not reported. Patient arrived in the emergency room at 15:55 and died at 16:40 from cardiovascular arrest on 08Apr2021. Absence of signs and symptoms attributable to anaphylactic shock. The patient died on 08Apr2021. It was not reported if an autopsy was performed. Event outcome was fatal.; Reported Cause(s) of Death: cardiovascular arrest


VAERS ID: 1235038 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-06
Onset:2021-04-07
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 1 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-07
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Benign prostatic hypertrophy; Hypertension
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021409130

Write-up: sudden death; This is as spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB with regulatory authority report number IT-MINISAL02-713690. A 74-year-old male patient received the first dose of BNT162B2 (COMIRNATY, Lot Number: ET7205) intramuscularly in right deltoid on 06Apr2021 at 0.3 mL, single for COVID-19 immunisation. Medical history included hypertension and benign prostatic hypertrophy. The patient''s concomitant medications were not reported. The patient experienced sudden death on 07Apr2021. It was not reported if an autopsy was performed. Reporter Comment: Request for death report and additional information to the reporting doctor, waiting for answer. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: Request for death report and additional information to the reporting doctor, waiting for answer; Reported Cause(s) of Death: sudden death


VAERS ID: 1235039 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-29
Onset:2021-04-07
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-07
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Solid tumour
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021414221

Write-up: sudden death; This is a spontaneous report received from a contactable pysician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is IT-MINISAL02-713945. A 57-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in left shoulder on 29Mar2021 08:46 (Batch/Lot Number: ET7205; Expiration Date: 31Jul2021) as 30 ug, single (at the age of 57-year-old) for covid-19 immunisation. Medical history included solid tumour. The patient''s concomitant medications were not reported. The patient experienced sudden death on 07Apr2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Sudden death


VAERS ID: 1235098 (history)  
Form: Version 2.0  
Age: 73.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-05
Onset:2020-04-05
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER2659 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: C-reactive protein, Infective spondylitis, Magnetic resonance imaging, Pyrexia, Sepsis, White blood cell count
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Sepsis (narrow), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-13
   Days after onset: 373
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Catheter placement; Haemodialysis; Renal failure chronic; Shunt occlusion
Allergies:
Diagnostic Lab Data: Test Date: 20210406; Test Name: CRP; Test Result: 28.3 mg/dl; Test Date: 202104; Test Name: MRI; Result Unstructured Data: Test Result:Pyogenic spondylitis (L2/3) noted; Test Date: 20210403; Test Name: Pyrexia; Result Unstructured Data: Test Result:38.0 Centigrade; Comments: In the evening; Test Date: 20210405; Test Name: Pyrexia; Result Unstructured Data: Test Result:38.4 Centigrade; Comments: In the evening; Test Date: 20210406; Test Name: White blood cells; Result Unstructured Data: Test Result:22100 /mm3
CDC Split Type: JPPFIZER INC2021417806

Write-up: Pyrexia; pyogenic spondylitis due to long-term placed catheter infection; Sepsis; This is an initial spontaneous report from a contactable physician received from the Agency Regulatory Authority. Regulatory authority report number v21101813. A 73-year-old male patient received the second dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number-ER2659; Expiration Date: 30Jun2021) via an unspecified route of administration on 05Apr2021 at 15:00 as a single dose and was previously administered the first dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as single dose for covid-19 immunization. The patient was 73-years-old at the time of vaccination. The patient had a medical history of renal failure chronic, haemodialysis (from 20Oct2020), shunt occlusion, and insertion of long term catheter (on 18Jan2021). The patient''s concomitant medications were not reported. On an unknown date, the patient previously received the first dose of BNT162b2 (COMIRNATY, Solution for injection). It was reported that, on an unspecified date, the patient experienced pyogenic spondylitis due to long-term placed catheter infection, on 05Apr2021 (the day of the vaccination), the patient experienced pyrexia and on an unspecified date in Apr2021 sepsis. The patient underwent lab tests and procedures which included c-reactive protein: 28.3 mg/dl on 06Apr2021, magnetic resonance imaging: pyogenic spondylitis (l2/3) noted on Apr2021. On 03Apr2021 in the evening, pyrexia: 38.4 centigrade on 05Apr2021 in the evening 38.0 centigrade. On 06Apr2021 (1 day after the vaccination), the patient visited fever outpatient of the hospital. At the visit, white blood cell count: 22100 /mm3 on 06Apr2021. On 06Apr2021 (1 day after the vaccination), the patient was admitted to the hospital. Patient was receiving conservative treatment with antibiotics. On 13Apr2021 (8 days after the vaccination), the patient died and was discharged. It was not reported if an autopsy was performed. The reporting physician classified the event, pyrexia as serious (hospitalized, medically significant). The reporting physician commented as follows; It was unknown as to whether the event was related to BNT162b2. Regarding other possible cause of the event such as any other diseases, the reporting physician commented as follows: The patient was being in haemodialysis due to renal failure chronic and experienced pyogenic spondylitis due to long-term placed catheter infection. The outcome of the events sepsis and pyogenic spondilytis was fatal and for pyrexia was unknown.; Reported Cause(s) of Death: Sepsis; pyogenic spondylitis due to long-term placed catheter infection


VAERS ID: 1235105 (history)  
Form: Version 2.0  
Age: 102.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-12
Onset:2021-04-13
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9480 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthma, Blood pressure measurement, Body temperature, Computerised tomogram, Oxygen saturation
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (narrow), Eosinophilic pneumonia (broad), Hypersensitivity (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-16
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: MINEBASE; THEOLONG; AMLODIPINE; TELMISARTAN
Current Illness: Pneumonia aspiration (Treatment with clarithromycin)
Preexisting Conditions: Medical History/Concurrent Conditions: Aortic valve incompetence; Aortic valve stenosis; Cardiac failure chronic; Hospitalization NOS; Tricuspid valve incompetence
Allergies:
Diagnostic Lab Data: Test Date: 20210415; Test Name: Blood pressure; Result Unstructured Data: Test Result:decreased; Test Date: 20210402; Test Name: Body temperature; Result Unstructured Data: Test Result:37.3 Centigrade; Comments: pyrexia; Test Date: 20210412; Test Name: Body temperature; Result Unstructured Data: Test Result:36.6 Centigrade; Comments: before vaccination; Test Date: 20210402; Test Name: CT; Result Unstructured Data: Test Result:Pneumonia aspiration; Test Date: 20210414; Test Name: SpO2; Test Result: 75 %
CDC Split Type: JPPFIZER INC2021425503

Write-up: Asthmatic attack; This is a spontaneous report from a contactable physician received from the regulatory authority. The regulatory authority report number is v21102060. A 102-year and 4-month-old female patient received the first dose of BNT162B2 (COMIRNATY, formulation: Solution for injection, Lot number ER9480, Expiration date 31Jul2021), via an unspecified route of administration on 12Apr2021 14:40 (at the age of 102-years and 4-months) as a single dose for COVID-19 immunization. Medical history included: ongoing pneumonia aspiration from 02Apr2021, cardiac failure chronic (aortic valve stenosis, aortic valve incompetence, tricuspid valve incompetence). On 24Mar2021, the patient was admitted to the hospital (hospitalization reason not specified). On 02Apr2021, the patient had pyrexia of 37.3 degrees Centigrade. Pneumonia aspiration was diagnosed based on the image of computed tomography (CT). Treatment with antibacterial drug of clarithromycin was started. The patient''s body temperature was 37.3 Centigrade on 02Apr2021, and before vaccination was 36.6 degree Centigrade on 12Apr2021. Concomitant medications included: clarithromycin (MINEBASE) from 02Apr2021, theophylline (THEOLONG), amlodipine, and telmisartan for an unspecified indication. On 12Apr2021 at 14:40 (the day of vaccination), the patient received the first dose of COMIRNATY. On 13Ap2021 around 21:00 (1 day after the vaccination), the patient experienced asthmatic attack. On 16Apr2021 (4 days after the vaccination) at 6:51, the patient died. The course of the event was as follows: On 13Apr2021 around 21:00 (1 day after the vaccination), intraoral sputum accumulation developed, and large volume of sputum was vacuumed. Moaning was noted but no wheezing was seen. On 14Apr2021 (2 days after the vaccination), the patient made reaction to verbal contact. At 18:40, labored respiration, moaning, and wheezing were noted. SpO2 decreased to 75%. Drugs including bronchodilator, steroid, and catecholamine were administered, but they were ineffective. Until 14Apr2021, the patient had no pyrexia. On 15Apr2021 (3 days after the vaccination), blood pressure decreased, and bradycardia developed. On 16Apr2021 at 6:51, the patient''s death was confirmed, and the patient left hospital mortality. The outcome of the event asthmatic attack was fatal. The reporting physician classified the event as serious (Death) and the causality between the event and BNT162b2 as unassessable. Other possible causes of the event such as any other diseases were bronchial asthma and cardiac failure.; Reported Cause(s) of Death: Asthmatic attack


VAERS ID: 1235238 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-11
Onset:2021-03-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP9605 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-12
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cataract; Eczema; Smoker
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021409092

Write-up: The patient died suddenly the day after the injection. I don''t know if it was a side effect, patient probably died of a myocardial infarction; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number NL-LRB-00483548, Safety Reportu Unique Identifier NL-LRB-00485690. A 79-years-old female patient received BNT162b2 (COMIRNATY), via an unspecified route of administration on 11Mar2021 (Lot Number: EP9605) as single dose for Covid-19 immunisation. Medical history included cataract, smoker, eczema. The patient''s concomitant medications were not reported. The patient died suddenly the day after the injection on 12Mar2021. The reporter did not know if it was a side effect, patient probably died of a myocardial infarction. The death is unlikely to be due to the vaccination. only report because it was close to the vaccination and it was an unexpected death. Patient lived independently, single. Not a clear picture of health, but went for a weekly walk with a group of friends. No medication. No home care. The reporter did not know if it is a side effect. Myocardial infarction is the most likely cause of death. No previous COVID-19 infection. No diagnostic procedures. The patient died on 12Mar2021. An autopsy was not performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: I don''t know if it was a side effect, patient probably died of a myocardial infarction


VAERS ID: 1235253 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-10
Onset:2021-03-13
   Days after vaccination:31
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Blood pressure measurement, Body temperature, Chromaturia, Confusional state, Fatigue, Heart rate, Hypophagia, Malaise, Oxygen saturation, Renal failure, Urine analysis
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Chronic kidney disease (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-22
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LEVODOPA
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No reported medical history)
Allergies:
Diagnostic Lab Data: Test Date: 20210321; Test Name: blood pressure; Test Result: Inconclusive; Result Unstructured Data: 155/135 mmhg; Test Date: 20210321; Test Name: body temperature; Test Result: Inconclusive; Result Unstructured Data: 36.3/min; Test Date: 20210321; Test Name: heartbeat; Test Result: Inconclusive; Result Unstructured Data: 68-90/min; Test Date: 20210322; Test Name: pulse; Test Result: Inconclusive; Result Unstructured Data: 90/min; Test Date: 20210321; Test Name: Saturation; Test Result: Inconclusive; Result Unstructured Data: variable 60-90%,; Test Date: 20210321; Test Name: urine stick; Test Result: Inconclusive; Result Unstructured Data: no increased leukocytes
CDC Split Type: NLMODERNATX, INC.MOD20210

Write-up: This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021. This regulatory authority case was reported by an other health care professional and describes the occurrence of RENAL FAILURE (not tested but looks like kidney failure), MALAISE (not feeling well), CHROMATURIA (dark urine), CONFUSIONAL STATE (some confusion), HYPOPHAGIA (drank with difficulty or not, 3 bites of bread) and FATIGUE (fatigue) in a 98-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 300042721) for COVID-19 vaccination. The patient''s past medical history included No adverse event (No reported medical history). Concomitant products included LEVODOPA for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced MALAISE (not feeling well) (seriousness criterion death), CONFUSIONAL STATE (some confusion) (seriousness criterion death) and FATIGUE (fatigue) (seriousness criterion death). On 20-Mar-2021, the patient experienced RENAL FAILURE (not tested but looks like kidney failure) (seriousness criterion death) and CHROMATURIA (dark urine) (seriousness criterion death). On 21-Mar-2021, the patient experienced HYPOPHAGIA (drank with difficulty or not, 3 bites of bread) (seriousness criterion death). The patient died on 22-Mar-2021. The cause of death was not reported. It is unknown if an autopsy was performed. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, Blood pressure measurement: 155/135 mmhg (Inconclusive) 155/135 mmhg. On 21-Mar-2021, Body temperature: 36.3/min (Inconclusive) 36.3/min. On 21-Mar-2021, Heart rate: 68-90/min (Inconclusive) 68-90/min. On 21-Mar-2021, Oxygen saturation: 60-90% (Inconclusive) wisselend 60-90%. On 21-Mar-2021, Urine analysis: no increases leukocytes (Inconclusive) no increased leucocytes. On 22-Mar-2021, Heart rate: 90 (Inconclusive) 90/min. For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications also included non specified anticoagulants. Treatment of these events were not reported. Reporter did not allow further contact; Reported Cause(s) of Death: unknown cause of death


Result pages: prev   1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1265&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166